COLTON JACKSON: Open Payments
NPI 1780339564 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 37 payments from 17 companies in 2025. Trend: 2023 $383 · 2024 $457 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Viatris Specialty LLC | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: REXULTI, EVENITY, Kerendia, OTEZLA, ZENPEP, Veozah, MOUNJARO, XIFAXAN.
Industry payments across NM — which companies pay providers there.
